Fast Five Quiz: Herpes Zoster Prevention in Adults Who Are Immunocompromised

Heidi Moawad, MD


May 04, 2023

Herpes zoster (HZ) is characterized by neuropathic pain and dermatomal vesicular rash owing to reactivation of varicella-zoster virus that laid dormant in the host, often for decades, after a primary infection of chickenpox (varicella).

The Canadian Immunization Guide recommends that people who are immunocompromised and ≥ 50 years of age are vaccinated against HZ (also known as shingles). In recent years, the scientific literature around HZ vaccination in patients who are immunocompromised has evolved, and new guidance is emerging.

How familiar are you with HZ prevention in adults who are immunocompromised? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.